Keywords: maxim, initiate, ph, ii, ceplene, trials, pharmaceuticals

Maxim to initiate Ph II Ceplene trials

Article | 08 November 2001

Print This

Maxim Pharmaceuticals plans to start a Phase II trial of Ceplene(histamine dihydrochloride), its candidate triple combination therapy for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in